California Public Employees Retirement System
SYRE icon

California Public Employees Retirement System’s Spyre Therapeutics SYRE Stock Holding History

California Public Employees Retirement System’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-834
Closed -$145K – 1479
2021
Q2 		$145K Sell
834
-2,578
-76% -$468K ﹤0.01% 1482
2021
Q1 		$676K Hold
3,412
– – ﹤0.01% 2773
2020
Q4 		$671K Sell
3,412
-72
-2% -$14.9K ﹤0.01% 2739
2020
Q3 		$618K Sell
3,484
-236
-6% -$43.7K ﹤0.01% 2628
2020
Q2 		$860K Buy
3,720
+2,080
+127% +$396K ﹤0.01% 2336
2020
Q1 		$191K Hold
1,640
– – ﹤0.01% 2874
2019
Q4 		$313K Buy
+1,640
New +$322K ﹤0.01% 2939

Other funds holding SYRE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

California Public Employees Retirement System's SYRE Position: Q3 2021 in Review

California Public Employees Retirement System sold out of Spyre Therapeutics (SYRE) in Q3 2021, closing a stake of 834 shares — an estimated $145K sold.

California Public Employees Retirement System first reported a position in SYRE in Q4 2019 and held it in 7 quarters. The position peaked at $860K in Q2 2020. 77 funds tracked by Wall St. Rank hold SYRE as of Q3 2021.

  • California Public Employees Retirement System reported no remaining Spyre Therapeutics position as of Q3 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 834 Spyre Therapeutics shares in Q3 2021, an estimated $145K.
  • California Public Employees Retirement System first reported a position in Spyre Therapeutics in Q4 2019 and held it in 7 quarters.
  • California Public Employees Retirement System's Spyre Therapeutics position peaked at $860K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2021.

Based on California Public Employees Retirement System's 13F filing for Q3 2021, filed 10 Nov 2021.